No abstract

Saphenous vein patch rupture after carotid endarterectomy is an infrequent but devastating complication. This study was undertaken to evaluate the material and structural properties of fresh human saphenous veins to understand the causes of this complication. Segments of saphenous veins were obtained from 22 patients from vein harvested during coronary artery bypass surgery. Ninety-three specimens, oriented in both circumferential (n = 45) and longitudinal (n = 48) directions, were prepared from the available vein segments for testing. Specimens were mounted on specially designed grips and then subjected to uniaxial tension testing. For each specimen the following material and structural parameters were determined: vessel diameter, tensile stiffness, failure and ultimate forces, and tensile modulus, failure stress, and strain. The physical properties of specimens evaluated in longitudinal orientations and thus limit the inherent strength of the vein. The physical properties of circumferentially tested vein specimens were negatively correlated to age, female gender, diabetes, and hypertension. The data obtained in this investigation suggest that age, hypertension, as well as diabetes and gender may adversely influence the circumferential tensile strength of human saphenous veins used as patch grafts.

The pathology of thrombophlebitis primarily results from the obliteration of venous valves in the lower extremities. The objective of this study was to develop a prosthetic venous valve that could be implanted in the human femoral system to ameliorate the deleterious effects of thrombophlebitis. Prosthetic venous valves were produced from two materials: Pellethane valves were fabricated from a dip-casting process; umbilical vein valves were produced by a fixation process. The valves were evaluated as implants within the external jugular veins of 10 research dogs. Each animal was implanted with one Pellethane valve in one external jugular vein and one umbilical vein venous valve in the contralateral jugular vein. Each valve was positioned over a stainless-steel cylinder that had been implanted into the jugular veins in such a manner that there existed no blood-cylinder interaction. Patency of the valves was determined by X-ray venography at 24, 48, and 72 h and at 5 and 8 days postoperatively. All of the umbilical vein venous valves were occluded by the end of 48 h, whereas two of the Pellethane venous valves remained patent for at least 5 days but were occluded at 8 days. The results of this study suggest the possibility of success of Pellethane valve implants in the venous circulation and indicate future directions for study.

The objective of this study was to compare the surface thrombogenicities of endothelial cell-seeded small-diameter vascular grafts with those of nonseeded contralateral grafts under conditions of acute controlled low blood flows through the grafts in a canine carotid artery model. Autologous venous endothelial cells seeded in the preclots onto 6 cm sections of 4 mm (internal diameter) double-velour Dacron grafts covered 15% and 80% of graft luminal surfaces at 3 and 5 weeks postsurgically, respectively. Contralateral nonseeded control graft lumina had pannus ingrowth of endothelium across the anastomoses only. There were significant differences in initial carotid graft blood flow rates between seeded and control grafts at both 3 and 5 weeks postsurgically. When blood flow was reduced to 30% of the initial flow levels for 4 hours through these grafts, endothelial cell-seeded grafts maintained patencies and mean blood flow returned to 63.3% and 93% of initial flow levels at 3 and 5 weeks postsurgically, respectively. Few thrombi accumulated. In contrast, thrombi accumulated on nonseeded graft lumina during restricted blood flow. Some nonseeded grafts occluded during low flows, and the ratios of final flow to initial flow were only 28% at 3 weeks and 20% at 5 weeks in these nonseeded grafts. These data demonstrate the efficacy of seeding autologous endothelial cells on small-diameter grafts in this canine model. If technically successful, endothelial cell seeding may provide a protocol for enhancement of the long-term implantation success of small-diameter vascular grafts used for human vascular repair and replacements.